Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT07145320
Eligibility Criteria:
Inclusion Criteria:
* Women aged between 18 and 65 years,
* Scheduled to receive adjuvant chemotherapy for the first time,
* Receiving the AC protocol as their chemotherapy regimen,
* Receiving chemotherapy doses classified as moderately emetogenic (according to the International Society of Supportive Care in Cancer Guidelines),
* Not having received radiotherapy prior to adjuvant chemotherapy,
* Without chronic diseases (coronary artery disease, chronic kidney disease, or diabetes mellitus),
* Not having used any non-pharmacological method for nausea and vomiting,
* Diagnosed with breast cancer for the first time,
* Without metastasis,
* Without thrombocytopenia,
* At an early stage,
* Aware of their diagnosis,
* Open to communication and cooperation,
* Literate,
* Not receiving psychiatric and/or depression treatment,
* Not in the terminal stage,
* Willing and volunteering to participate in the study.
Exclusion Criteria:
* Illiterate,
* Over 65 years of age,
* Using anxiolytic or antidepressant medications,
* Having chronic diseases (gastrointestinal obstruction/disease, hepatitis, coronary artery disease, chronic kidney disease, or diabetes mellitus),
* Having metastasis,
* Having received radiotherapy prior to adjuvant chemotherapy,
* Not willing to participate in the study.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07145320
Study Brief:
Protocol Section:
NCT07145320